[go: up one dir, main page]

FI813884L - ANTIMYKOTISKA MEDEL MED HOEGRE FRIGIVNING AV VERKNINGSMEDLEN - Google Patents

ANTIMYKOTISKA MEDEL MED HOEGRE FRIGIVNING AV VERKNINGSMEDLEN

Info

Publication number
FI813884L
FI813884L FI813884A FI813884A FI813884L FI 813884 L FI813884 L FI 813884L FI 813884 A FI813884 A FI 813884A FI 813884 A FI813884 A FI 813884A FI 813884 L FI813884 L FI 813884L
Authority
FI
Finland
Prior art keywords
isopropyl
weight
acid esters
agents
active compounds
Prior art date
Application number
FI813884A
Other languages
Finnish (fi)
Other versions
FI813884A7 (en
Inventor
Miklos Von Bittera
Karl Heinz Buechel
Manfred Plempel
Erich Regel
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6118424&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FI813884(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of FI813884A7 publication Critical patent/FI813884A7/en
Publication of FI813884L publication Critical patent/FI813884L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7015—Drug-containing film-forming compositions, e.g. spray-on
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Body Structure For Vehicles (AREA)
  • Catching Or Destruction (AREA)
  • Stereophonic Arrangements (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

1. Claims for the Contracting States : BE, CH, DE, FR, GB, IT, LI, NL, SE Antimycotic agents having a higher degree of release of the active compounds and containing azole derivatives, solvents and customary formulation auxiliaries, characterised in that they contain as spreading agents 2 to 10% by weight of isopropyl myristate, isopropyl palmitate, isopropyl stearate, carprylic/capric acid esters of saturated fatty alcohols of C12 -C18 chain lenght, waxy fatty acid esters, silicone oils, an isopropyl myristate/isopropyl palmitate/isopropyl stearate mixture or coconut oil acid isopropyl ester, as solubilisers 1 to 8% by weight of benzyl alcohol, 2-octyl-dodecanol, polyethylene glycols, phthalates, adipates, propylene glycol, glycerol, di- or tripropylene glycol or waxes and as film-forming agents 10-12 parts by weight of cellulose ether per 100 parts by volume of the end product. 1. Patent Claims for the Contracting State : AT Process for the preparation of antimycotics based on azole derivative active compounds and customary formulation auxiliaries, characterised in that the active compounds and formulation auxiliaries are formulated together with 2 to 10% by weight of isopropyl myristate, isopropyl palmitate, isopropyl stearate, caprylic/capric acid esters of saturated fatty alcohols of C12 -C18 chain length, waxy fatty acid esters, silicone oils, an isopropyl myristate/isopropyl palmitate/isopropyl stearate mixture or coconut oil acid isopropyl ester as spreading agents, with 1 to 8% by weight of benzyl alcohol, 2-octyl-dodecanol, polyethylene glycols, phthalates, adipates, propylene glycol, glycerol, di- or tripropylene glycol as solubilisers and with 10 to 15% by weight of cellulose ethers as film-forming agents, based in each case on the total weight.
FI813884A 1980-12-05 1981-12-03 ANTIMYKOTISKA MEDEL MED HOEGRE FRIGIVNING AV VERKNINGSMEDLEN FI813884L (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19803045915 DE3045915A1 (en) 1980-12-05 1980-12-05 ANTIMYCOTIC AGENTS WITH HIGH ACTIVE SUBSTANCE RELEASE IN THE FORM OF ELASTIC LIQUID PLASTERS

Publications (2)

Publication Number Publication Date
FI813884A7 FI813884A7 (en) 1982-06-06
FI813884L true FI813884L (en) 1982-06-06

Family

ID=6118424

Family Applications (1)

Application Number Title Priority Date Filing Date
FI813884A FI813884L (en) 1980-12-05 1981-12-03 ANTIMYKOTISKA MEDEL MED HOEGRE FRIGIVNING AV VERKNINGSMEDLEN

Country Status (12)

Country Link
EP (1) EP0055396B1 (en)
JP (1) JPS57122016A (en)
AT (1) ATE11369T1 (en)
AU (1) AU546450B2 (en)
CA (1) CA1175354A (en)
DE (2) DE3045915A1 (en)
DK (1) DK538381A (en)
FI (1) FI813884L (en)
IL (1) IL64435A (en)
NO (1) NO813931L (en)
PH (1) PH17277A (en)
ZA (1) ZA818432B (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3243546A1 (en) * 1982-11-25 1984-05-30 Bayer Ag, 5090 Leverkusen ANTIMYCOTIC AGENTS IN GEL FOR TREATING FUNGAL INFECTIONS OF THE ORAL CAVES
EP0117811A3 (en) * 1983-02-23 1987-06-03 Sanofi S.A. Fungicidal pharmaceutical compositions for oral administration
FR2541114B1 (en) * 1983-02-23 1986-04-11 Sanofi Sa ANTIFUNGAL PHARMACEUTICAL COMPOSITIONS FOR ORAL USE CONTAINING OMOCONAZOLE
DE3311701A1 (en) * 1983-03-30 1984-10-04 Bayer Ag ANTIMYCOTIC AGENTS WITH HIGH ACTIVE SUBSTANCE RELEASE IN THE FORM OF CREAM
DE3311700A1 (en) * 1983-03-30 1984-10-04 Bayer Ag ANTIMYCOTIC AGENTS WITH HIGH ACTIVE SUBSTANCE RELEASE IN THE FORM OF SOLUTION AND SPRAY
JPS6058914A (en) * 1983-09-12 1985-04-05 Shionogi & Co Ltd Antimycotic gel preparation for external use containing imidazoles
CA1241602A (en) * 1984-02-23 1988-09-06 Ortho Pharmaceutical Corporation Antifungal aerosol solution
JPS61151117A (en) * 1984-12-25 1986-07-09 Bayer Yakuhin Kk Gelatinous antimycotic preparation
EP0215072A4 (en) * 1985-03-13 1990-01-08 Gluck Bruno A Antiseptic fluids.
HU200914B (en) * 1987-03-09 1990-09-28 Horvath Gyoengyi Lengyelne Process for producing new medical dosage unit suitable for local treatment of fungus infection of nails
JPH0725675B2 (en) * 1989-05-08 1995-03-22 ホーユー株式会社 Liquid mycosis agent
JP2555555B2 (en) * 1991-07-03 1996-11-20 武田薬品工業株式会社 Antifungal topical formulation
GB9408545D0 (en) * 1994-04-29 1994-06-22 Zyma Sa Compositions
FR2732223B1 (en) * 1995-03-30 1997-06-13 Sanofi Sa PHARMACEUTICAL COMPOSITION FOR TRANSDERMAL ADMINISTRATION
PT1150661E (en) * 1999-02-05 2004-02-27 Cipla Ltd PRODUCT FOR SPRAYING FOR TOPIC APPLICATION
US6962691B1 (en) 1999-05-20 2005-11-08 U & I Pharmaceuticals Ltd. Topical spray compositions
US8697753B1 (en) 2013-02-07 2014-04-15 Polichem Sa Method of treating onychomycosis

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3476853A (en) * 1965-04-13 1969-11-04 Colgate Palmolive Co Sprayed opaque bandage composition
DE2333335A1 (en) * 1973-06-29 1975-01-23 Siemens Ag Spring wire contact for cross-bar switches - has contact element at free end of spring contact in wire axial direction
JPS50129728A (en) * 1974-04-05 1975-10-14
DE2430039C2 (en) * 1974-06-22 1983-11-10 Bayer Ag, 5090 Leverkusen Climbazole in cosmetic products
DE2461406C2 (en) * 1974-12-24 1984-06-14 Bayer Ag, 5090 Leverkusen Azolyl- (1) -methanes and their salts, processes for their preparation and medicaments containing them
DE2628421A1 (en) * 1976-06-24 1978-01-05 Bayer Ag ANTIMICROBIAL AGENTS
JPS53139719A (en) * 1977-05-12 1978-12-06 Terumo Corp Antibacterial coating composition
DE2811916A1 (en) * 1978-03-18 1979-09-27 Bayer Ag Antimycotic 1-phenoxy-1-azolyl-4-halo-2-acyloxy-butane derivs. - prepd. by acylation of corresp. 1-imidazolyl-or 1-triazolyl-2-butanol derivs.

Also Published As

Publication number Publication date
ATE11369T1 (en) 1985-02-15
IL64435A0 (en) 1982-03-31
PH17277A (en) 1984-07-06
DE3045915A1 (en) 1982-07-08
ZA818432B (en) 1982-11-24
DE3168543D1 (en) 1985-03-07
FI813884A7 (en) 1982-06-06
EP0055396A1 (en) 1982-07-07
AU7826281A (en) 1982-06-10
JPS57122016A (en) 1982-07-29
CA1175354A (en) 1984-10-02
IL64435A (en) 1985-03-31
EP0055396B1 (en) 1985-01-23
DK538381A (en) 1982-06-06
AU546450B2 (en) 1985-09-05
NO813931L (en) 1982-06-07

Similar Documents

Publication Publication Date Title
DE3168402D1 (en) Anti-fungal composition in emulsion form with a higher release rate of the drug
FI813884L (en) ANTIMYKOTISKA MEDEL MED HOEGRE FRIGIVNING AV VERKNINGSMEDLEN
FI813885L (en) ANTIMYKOTISKA MEDEL MED HOEG FRIGIVNING AV VERKNINGSMEDEL I FOM AV ELASTISKA VAETSKE-PLAOSTER
EP0085882A2 (en) Antimycotic tampons with high release of active agent
PT786986E (en) PHARMACEUTICAL FORMULATIONS
US4457938A (en) Antimycotic agent, in the form of sticks, with a high release of active compound
US4745103A (en) Hair cosmetic composition
SE7709016L (en) 1- (2-ARYL-2-R-ETHYL) -1H-1,2,4-TRIAZOLES
DE3315522C2 (en)
GB754844A (en) Skin protective composition
KR930007446A (en) Pharmaceutical composition for rectal administration containing triazole derivatives
ES8503947A1 (en) Antimycotic Agent With a High Release of Active Compounds, in the Form of a Cream
GB762135A (en) Pharmaceutical compositions comprising pregnenolone-3-lower alkyl ethers

Legal Events

Date Code Title Description
FA Application withdrawn [patent]

Owner name: BAYER AKTIENGESELLSCHAFT